With this grant IXA stimulates the receiver to validate physics related research towards exploitation in cooperation with an industrial partner. The Physics2Market grant is meant for situations in which companies are hesitant to invest but need further confirmation that a science-based concept can become reality before they agree on cooperating. The primary criteria are:
Researchers (permanent staff, incl. tenure track) of the IXA partner organizations: HvA, UvA, VU, Amolf and Nikhef.
The budget per project is 10 to 35k€. This can be spent on personnel costs, consumables and small, well-motivated investments.
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]News
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]News
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]News